Company intelligence / Profile preview

VivaCell Biotechnology

Denzlingen, Baden-Württemberg, Germanyvivacell.de ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

VivaCell Biotechnology specializes in the discovery and development of synthetic or semi-synthetic drug candidates targeting neurovascular and neurodegenerative diseases. The company also provides contract research services using in vitro and ex vivo models to validate health benefits of pharmaceuticals, nutraceuticals, cosmetics, food products, and natural substances. Recent publications highlight work with cannabinoids in fibrosis and inflammation models. The company was acquired by CDMO firm "1Q Health" in April 2025 to expand testing/development capabilities focused on vascular/neurodegenerative disease areas.

Therapeutic areas: CardiovascularNephrologyNeurology
Modalities: Small molecule (synthetic and semi-synthetic drug candidates)Possibly biologics/natural products
Industry: Biotech

Partnerships

Member of Novobiome project consortium/Eureka Eurostars funding ("E!11342")ASPIRANT interdisciplinary project participant

Beyond the preview

Go deeper on VivaCell Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VivaCell Biotechnology.